反応式
[CH3:1][C:2]([OH:16])([C:4]([C:6]1[CH:11]=[CH:10][C:9]([O:12][CH2:13][CH2:14][OH:15])=[CH:8][CH:7]=1)=[O:5])[CH3:3].[C:17]1(=[O:23])[O:22][C:20](=[O:21])[CH2:19][CH2:18]1>>[CH3:3][C:2]([OH:16])([C:4]([C:6]1[CH:11]=[CH:10][C:9]([O:12][CH2:13][CH2:14][OH:15])=[CH:8][CH:7]=1)=[O:5])[CH3:1].[CH2:19]([C:20]([O-:5])=[O:21])[CH2:18][C:17]([O-:22])=[O:23]参加物
3
実験手順
As an illustrative example, a tri-functional compound can be prepared as follows. Irgacure 2959 (4-(2-hydroxyethoxy)phenyl-(2-hydroxy-2-propyl)ketone) can be reacted with succinic anhydride (reflux in triethylamine/Toluene) to obtain Irgacure 2959-monosuccinate. Norbloc (2-{3-(2H-Benxotriazol-2-yl)-4-hydroxyphenyl}ethyl methacrylate) is reacted with the obtained Irgacure 2959-monosuccinate in the presence of N,N-dicyclohexyl carbodiimide (DCC) and 4-(dimethylamino)pyridine (D-MAP) to obtain conjugated Irgacure 2959-Norbloc.
出典と根拠
- ORDレコード
- ord-3bd98ddf18f84b69902ca67453ad2153
- 出典データセット
- uspto-grants-2013_04
- 特許番号
- US08431624B2
関連ノート
読み込み中…